Home » Stocks » EVGN

Evogene Ltd. (EVGN)

Stock Price: $6.05 USD -0.66 (-9.78%)
Updated Feb 25, 2021 3:59 PM EST - Market closed
After-hours: $5.77 -0.28 (-4.55%) Feb 25, 7:49 PM
Market Cap 204.61M
Revenue (ttm) 753,000
Net Income (ttm) -18.11M
Shares Out 25.75M
EPS (ttm) -0.82
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 25
Last Price $6.05
Previous Close $6.70
Change ($) -0.66
Change (%) -9.78%
Day's Open 6.61
Day's Range 5.76 - 6.66
Day's Volume 1,874,592
52-Week Range 0.75 - 10.24

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 1 day ago

TEL AVIV and REHOVOT, Israel, Feb. 24, 2021 /PRNewswire/ -- Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. (TASE: TKUN), a leading medical cannabis company, and Canonic Ltd., a subsidia...

PRNewsWire - 1 month ago

REHOVOT, Israel, Jan. 20, 2021 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ...

PRNewsWire - 2 months ago

REHOVOT, Israel, Dec. 23, 2020 /PRNewswire/ -- Canonic Ltd, a company focused on the development of medical cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE...

24/7 Wall Street - 2 months ago

While most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Other stocks mentioned: AR, MGY, NBEV, AGS
Seeking Alpha - 3 months ago

Evogene Ltd. (EVGN) CEO Ofer Haviv on Q3 2020 Results - Earnings Call Transcript

PRNewsWire - 3 months ago

REHOVOT, Israel, Nov. 18, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development ac...

PRNewsWire - 3 months ago

REHOVOT, Israel, Nov. 2, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across ...

PRNewsWire - 3 months ago

REHOVOT, Israel, Oct. 30, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company focused on revolutionizing product discovery and development i...

Seeking Alpha - 5 months ago

Despite its recent share price increase, Evogene continues to be undervalued given the sum of parts valuation of its 4 main subsidiaries and $45 million cash position.

PRNewsWire - 5 months ago

REHOVOT, Israel, Sept. 9, 2020 /PRNewswire/ -- Evogene Ltd.

Seeking Alpha - 5 months ago

Evogene: Hidden Gems Of Computational Predictive Biology (Part 3 Of 4) - Ag Plenus (Novel Herbicides And Pesticides)

PRNewsWire - 5 months ago

REHOVOT, Israel, Sept. 1, 2020 /PRNewswire/ -- Evogene Ltd.

Seeking Alpha - 6 months ago

Evogene: Hidden Gems Of Computational Predictive Biology, Part 2 Of 4 - Lavie Bio

PRNewsWire - 6 months ago

REHOVOT, Israel, Aug. 19, 2020 /PRNewswire/ -- Evogene Ltd.

Seeking Alpha - 6 months ago

Evogene Ltd. has developed a unique Computational Predictive Biology platform, leveraging big data and artificial intelligence to life-science products such as microbes, small molecules and ge...

Seeking Alpha - 6 months ago

Evogene Ltd. (EVGN) CEO Ofer Haviv on Q2 2020 Results - Earnings Call Transcript

PRNewsWire - 6 months ago

REHOVOT, Israel, July 29, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading artificial intelligence company targeting to revolutionize life-science product developmen...

PRNewsWire - 7 months ago

REHOVOT, Israel, July 15, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development ...

PRNewsWire - 8 months ago

REHOVOT, Israel, June 3, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development a...

Seeking Alpha - 8 months ago

Evogene Ltd (EVGN) CEO Ofer Haviv on Q1 2020 Results - Earnings Call Transcript

PRNewsWire - 8 months ago

REHOVOT, Israel, May 26, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development a...

PRNewsWire - 9 months ago

REHOVOT, Israel, May 20, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development a...

Seeking Alpha - 11 months ago

Evogene's (EVGN) CEO Ofer Haviv on Q4 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Evogene's (EVGN) CEO Ofer Haviv on Q3 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Evogene Ltd (EVGN) CEO Ofer Haviv on Q2 2019 Results - Earnings Call Transcript

Benzinga - 1 year ago

Evogene Ltd. (NASDAQ: EVGN) is amending its collaboration with Bayer AG (OTC: BAYRY)'s crop science division to identify genome editing targets for evaluation against a broad range of corn dis...

Other stocks mentioned: BAYRY
GuruFocus - 1 year ago

In the small- and micro-cap section of the market, there's a whole selection of companies that are trading at what look to be deeply discounted valuations right now.

Other stocks mentioned: HCHC, NVFY
Seeking Alpha - 1 year ago

Evogene Ltd. (EVGN) CEO Ofer Haviv on Q1 2019 Results - Earnings Call Transcript

Benzinga - 1 year ago

It's not unusual these days to see agri-tech and biotech stocks jumping on the cannabis bandwagon to capitalize on the opportunity presented by the geographically expanding legalization of pot.

24/7 Wall Street - 1 year ago

Agricultural engineering company Evogene Ltd. has announced the establishment of a new subsidiary, called Canonic, to develop next-generation medical cannabis product

About EVGN

Evogene, together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and gene... [Read more...]

Industry
Biotechnology
Founded
1999
CEO
Ofer Haviv
Employees
143
Stock Exchange
NASDAQ
Ticker Symbol
EVGN
Full Company Profile

Financial Performance

In 2019, Evogene's revenue was $753,000, a decrease of -56.90% compared to the previous year's $1.75 million. Losses were -$18.11 million, -12.75% less than in 2018.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for Evogene stock is "Strong Buy" and the 12-month stock price forecast is 15.00.

Price Target
$15.00
Analyst Consensus: Strong Buy